Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Investing in agricultural land is the way to go - Part Two

Friday, August 27, 2010

Benedicte Gravrand, Opalesque London:

Part One, published yesterday, can be accessed here.

Agricultural investing, even with its shortcomings, is attracting interest from investors and from fund managers. The main reasons for are, for one, the rising global population and the dwindling available land; and secondly, the search for an inflation hedge and for real assets which are uncorrelated to financial markets.

And some managers argue that investing in food is not enough: buying the land that grows them - as a fixed resource - should be an integral part of an agricultural portfolio.

Investing in land Many fund managers agree that agri investing is good for diversification, although not for long-only investing. And there is another thing they seem to agree on: investing in land is the way to go.

Research from consulting firm HighQuest Partners shows total cultivated land (globally) stands at 1,400 million hectares and has not changed in 20 years. An additional 80-100 million hectares of land will be needed to meet the anticipated demand for major crops in the next decade (see Opalesque Exclusive here).

In a recent Opalesque video intervi......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its